Human Molecular Genetics Advance Access originally published online on October 5, 2005
Human Molecular Genetics 2005 14(22):3477-3492; doi:10.1093/hmg/ddi377
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism


1Human Molecular Genetics Unit, Dibit-San Raffaele Scientific Institute, Milan, 2IRCCS CSS, Mendel Institute, Rome, 3Department of Experimental Medicine and Pathology, La Sapienza University, Rome and 4Vita-Salute San Raffaele University, Milan, Italy
* To whom correspondence should be addressed at: Human Molecular Genetics Unit, San Raffaele Scientific University Institute, DIBIT, Via Olgettina 58, 20132 Milan, Italy. Tel: +39 0226433502/4721/4947; Fax: +39 0226434767; Email: casari.giorgio{at}hsr.it
Received August 18, 2005; Accepted September 29, 2005
Parkinson's disease (PD) is a progressive neurodegenerative illness associated with a selective loss of dopaminergic neurons in the nigrostriatal pathway of the brain. Despite the overall rarity of the familial forms of PD, the identification of single genes linked to the disease has yielded crucial insights into possible mechanisms of neurodegeneration. Recently, a putative mitochondrial kinase, PINK1, has been found mutated in an inherited form of parkinsonism. Here, we describe that PINK1 mutations confer different autophosphorylation activity, which is regulated by the C-terminal portion of the protein. We also demonstrate the mitochondrial localization of both wild-type and mutant PINK1 proteins unequivocally and prove that a short N-terminal part of PINK1 is sufficient for its mitochondrial targeting.
These authors contributed equally.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Zhou, Y. Huang, Y. Shao, J. May, D. Prou, C. Perier, W. Dauer, E. A. Schon, and S. Przedborski The kinase domain of mitochondrial PINK1 faces the cytoplasm PNAS, August 19, 2008; 105(33): 12022 - 12027. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Anichtchik, H. Diekmann, A. Fleming, A. Roach, P. Goldsmith, and D. C. Rubinsztein Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish J. Neurosci., August 13, 2008; 28(33): 8199 - 8207. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gautier, T. Kitada, and J. Shen From the Cover: Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress PNAS, August 12, 2008; 105(32): 11364 - 11369. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, Y. Ouyang, L. Yang, M. F. Beal, A. McQuibban, H. Vogel, and B. Lu Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery PNAS, May 13, 2008; 105(19): 7070 - 7075. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Devi, V. Raghavendran, B. M. Prabhu, N. G. Avadhani, and H. K. Anandatheerthavarada Mitochondrial Import and Accumulation of {alpha}-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain J. Biol. Chem., April 4, 2008; 283(14): 9089 - 9100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Y. Hui, A. M. Andres, A. K. Miller, N. J. Spann, D. W. Potter, N. M. Post, A. Z. Chen, S. Sachithanantham, D. Y. Jung, J. K. Kim, et al. Txnip balances metabolic and growth signaling via PTEN disulfide reduction PNAS, March 11, 2008; 105(10): 3921 - 3926. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weihofen, B. Ostaszewski, Y. Minami, and D. J. Selkoe Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1 Hum. Mol. Genet., February 14, 2008; 17(4): 602 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Badugu, M. Garcia, V. Bondada, A. Joshi, and J. W. Geddes N Terminus of Calpain 1 Is a Mitochondrial Targeting Sequence J. Biol. Chem., February 8, 2008; 283(6): 3409 - 3417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Poole, R. E. Thomas, L. A. Andrews, H. M. McBride, A. J. Whitworth, and L. J. Pallanck The PINK1/Parkin pathway regulates mitochondrial morphology PNAS, February 5, 2008; 105(5): 1638 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Davies, K. A. Powell, K. E. White, W. Yip, V. Hogan, A. J. Hollins, J. R. Davies, M. Piechota, D. G. Brownstein, S. J. Moat, et al. A missense mutation in the murine Opa3 gene models human Costeff syndrome Brain, February 1, 2008; 131(2): 368 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Klein and M. G. Schlossmacher Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder Neurology, November 27, 2007; 69(22): 2093 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Exner, B. Treske, D. Paquet, K. Holmstrom, C. Schiesling, S. Gispert, I. Carballo-Carbajal, D. Berg, H.-H. Hoepken, T. Gasser, et al. Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin J. Neurosci., November 7, 2007; 27(45): 12413 - 12418. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scheele, A. R. Nielsen, T. B. Walden, D. A. Sewell, C. P. Fischer, R. J. Brogan, N. Petrovic, O. Larsson, P. A. Tesch, K. Wennmalm, et al. Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J, November 1, 2007; 21(13): 3653 - 3665. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thomas and M. F. Beal Parkinson's disease Hum. Mol. Genet., October 15, 2007; 16(R2): R183 - R194. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kitada, A. Pisani, D. R. Porter, H. Yamaguchi, A. Tscherter, G. Martella, P. Bonsi, C. Zhang, E. N. Pothos, and J. Shen From the Cover: Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice PNAS, July 3, 2007; 104(27): 11441 - 11446. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mandemakers, V. A. Morais, and B. De Strooper A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases J. Cell Sci., May 15, 2007; 120(10): 1707 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hatano, S.-i. Kubo, S. Imai, M. Maeda, K. Ishikawa, Y. Mizuno, and N. Hattori Leucine-rich repeat kinase 2 associates with lipid rafts Hum. Mol. Genet., March 15, 2007; 16(6): 678 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Sim, D. S. S. Lio, S. S. Mok, C. L. Masters, A. F. Hill, J. G. Culvenor, and H.-C. Cheng C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1 Hum. Mol. Genet., November 1, 2006; 15(21): 3251 - 3262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, L. Qian, H. Xiong, J. Liu, W. S. Neckameyer, S. Oldham, K. Xia, J. Wang, R. Bodmer, and Z. Zhang From the Cover: Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila PNAS, September 5, 2006; 103(36): 13520 - 13525. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, J.-W. Wang, L. Yang, M. F. Beal, H. Vogel, and B. Lu Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin PNAS, July 11, 2006; 103(28): 10793 - 10798. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gandhi, M. M. K. Muqit, L. Stanyer, D. G. Healy, P. M. Abou-Sleiman, I. Hargreaves, S. Heales, M. Ganguly, L. Parsons, A. J. Lees, et al. PINK1 protein in normal human brain and Parkinson's disease Brain, July 1, 2006; 129(7): 1720 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tang, H. Xiong, P. Sun, Y. Zhang, D. Wang, Z. Hu, Z. Zhu, H. Ma, Q. Pan, J.-h. Xia, et al. Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease Hum. Mol. Genet., June 1, 2006; 15(11): 1816 - 1825. [Abstract] [Full Text] [PDF] |
||||







